Mallinckrodt Ch. 11 Audience begins with evaluation questions


By Rick Archer (Nov 1, 2021, 5:40 p.m. EDT) – Mallinckrodt’s Chapter 11 plan confirmation hearing opened in Delaware bankruptcy court on Monday with testimony and questions regarding the manufacturer’s worth of drugs and the amount of money that could be collected if the case passed from reorganization to liquidation.

Mallinckrodt’s value was criticized in the virtual hearing when a group of antitrust crimes asked if the valuation report was too optimistic about the company’s future performance and if the liquidation report was too pessimistic about the the price he could get for his non-opioid drugs.

Mallinckrodt and its subsidiaries filed for Chapter 11 a year ago, with a restructuring support agreement to reduce …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific case articles and topics and more!



Comments are closed.